The past year has seen significant advances in the epidemiology and management of thyroid cancer. This includes a better understanding of the increasing incidence of thyroid cancer worldwide, reclassification of a subtype of papillary thyroid cancer as non‐invasive neoplasm, significant changes to TNM staging of thyroid cancer which take effect in 2018, and slow progress in understanding the genetic basis of familial nonmedullary thyroid cancer.
|Number of pages||1|
|Publication status||Published - Jun 2018|
|Event||Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB) - Perth, Australia|
Duration: 27 Aug 2017 → 30 Aug 2017